Dr. Bisen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13900 Katy Freeway
Houston, TX 77079Phone+1 713-563-9600Fax+1 281-646-4351
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2019
The University of Texas at DallasM.B.A., Healthcare Leadership and Administration, High Distinction, 2016 - 2018
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2009 - 2012
St. George's University School of MedicineClass of 2009
Certifications & Licensure
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2013 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.Clinton Yam, Miral Patel, Holly A Hill, Ryan Sun, Roland L Bassett Jr
Cancer Research Communications. 2024-10-01 - Dose-Dense Chemotherapy Regimen for Breast Cancer Associated with Significant Decline in Ovarian Reserve.Isaac J Chamani, Alexandra Gannon, Phillip T Connell, Ajit Bisen, Ertug Kovanci
Journal of Adolescent and Young Adult Oncology. 2024-06-01 - 58 citationsPhase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosisDavid E. Gerber, M. Shaalan Beg, Farjana J. Fattah, Arthur E. Frankel, Oluwatomilade Fatunde
British Journal of Cancer. 2018-10-15
Press Mentions
Breast Cancer Survivor and Employee: MD Anderson Is the Only Place to BeMay 9th, 2023
Clinical Trial Eligibility Criteria a Growing ObstacleAugust 14th, 2017- Deep Vein Thrombosis as a Side Effect of Cancer: 9 Things to KnowAugust 8th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
